Nemus Bioscience, Inc. (NMUS) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 21 transactions totaling $241.9K, demonstrating a bearish sentiment with -$241.9K in net insider flow. The most recent transaction on Dec 27, 2018 involved a transaction of 37,667 shares valued at $0.
No significant insider buying has been recorded for NMUS in the recent period.
No significant insider selling has been recorded for NMUS in the recent period.
Based on recent SEC filings, insider sentiment for NMUS is bearish with an Insider Alignment Score of 0/100 and a net flow of -$241.9K. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Nemus Bioscience, Inc. (NMUS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading NMUS stock, having executed 21 transactions in the past 90 days. The most active insider is Health Sciences Inc. Emerald (Executive), who has made 5 transactions totaling $3.2M.
Get notified when executives and directors at NMUS file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 27, 2018 | Sciences Inc. Emerald Health | Executive | Other | 37,667 | $N/A | $0 | |
| Jul 23, 2018 | A. Cesario Douglas | Executive | Award | 643,501 | $N/A | $0 | |
| Mar 29, 2018 | Sciences Inc. Emerald Health | Executive | Conversion | 12,335,000 | $0.10 | $1.2M | Large |
| Mar 29, 2018 | Sciences Inc. Emerald Health | Executive | Conversion | 20,000,000 | $0.10 | $2.0M | Large |
| Feb 16, 2018 | Sciences Inc. Emerald Health | Executive | Purchase | 15,000,000 | $N/A | $0 | |
| Jan 24, 2018 | Sciences Inc. Emerald Health | Executive | Exercise | 1,781,250 | $N/A | $0 | |
| Jan 18, 2018 | Berecz Elizabeth | Executive | Award | 700,000 | $N/A | $0 | |
| Jan 18, 2018 | N. Lykos Cosmas | Executive | Award | 900,000 | $N/A | $0 | |
| Jan 18, 2018 | Stuart Murphy Brian | Executive | Award | 900,000 | $N/A | $0 | |
| Mar 13, 2017 | Alexander Lapham Reg | Executive | Exercise | 119,700 | $1.00 | $119.7K | |
| Oct 20, 2015 | Stuart Murphy Brian | Executive | Award | 375,000 | $N/A | $0 | |
| Oct 20, 2015 | Berecz Elizabeth | Executive | Award | 350,000 | $N/A | $0 | |
| Oct 20, 2015 | N. Lykos Cosmas | Executive | Award | 325,000 | $N/A | $0 | |
| Oct 20, 2015 | George Thomas | Executive | Award | 60,000 | $N/A | $0 | |
| Oct 20, 2015 | W. Mclaughlin Gerald | Executive | Award | 30,000 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Conversion(C) | 4 | $3.2M | 89.9% |
Sale(S) | 3 | $241.9K | 6.7% |
Exercise (Options)(X) | 2 | $119.7K | 3.3% |
Other(J) | 1 | $0 | 0.0% |
Award(A) | 10 | $0 | 0.0% |
Purchase(P) | 1 | $0 | 0.0% |
Insider selling pressure at Nemus Bioscience, Inc. has increased, with 10 insiders executing 21 transactions across all time. Total sales of $241.9K significantly outpace purchases of $0, resulting in a net outflow of $241.9K. This selling activity appears largely discretionary, which may warrant closer attention from investors.